NPP 150 by Dragon Pharma

Dragon Pharma Original Formula

Nandrolone Phenylpropionate

NPP 150150 mg/ml
Ester Phenylpropionate
Half-Life ~5 days
Anabolic Ratio 125
Androgenic Ratio 37
Carrier MCT Oil
Form Injection, 10ml
Availability: In Stock
$53.00
Quantity
Shipping
Wishlist

Nandrolone Phenylpropionate — NPP 150 by Dragon Pharma

NPP 150 is Dragon Pharma's formulation of injectable Nandrolone Phenylpropionate at 150mg/ml — the original short-ester form of Nandrolone that predates Deca-Durabolin by several years. Each 10ml vial in Dragon Pharma's MCT oil carrier delivers the same anabolic compound as Deca 300, but with a shorter ester that fundamentally changes its cycle dynamics, side effect management and detection window.

Also searched as: NPP 150mg, Nandrolone Phenylpropionate, Durabolin (original), NPP Dragon Pharma.

NPP Is the Original Nandrolone — The Historical Context

A fact rarely mentioned in competitor content: Nandrolone Phenylpropionate is not a shorter-ester variant of Deca — it is the original:

  • Nandrolone Phenylpropionate was first introduced commercially as "Durabolin" by Organon in 1959
  • Nandrolone Decanoate ("Deca-Durabolin") was introduced later in 1962 as a longer-acting version designed for less frequent injection
  • NPP was therefore the compound bodybuilders and athletes used throughout the 1960s before Deca replaced it in mainstream use due to the convenience of weekly injections
  • The modern resurgence of NPP reflects a shift back toward shorter esters for better cycle control — NPP is now often preferred by experienced users precisely because of what makes Deca inconvenient: its very long ester

NPP vs Deca — Quantified Ester Comparison

The same active compound, fundamentally different pharmacokinetics:

Parameter NPP 150 (Phenylpropionate) Deca 300 (Decanoate)
Ester Phenylpropionate Decanoate
Half-life ~5 days ~15 days
Time to steady-state ~25 days (5 half-lives) ~75 days (5 half-lives)
Minimum cycle length 8–10 weeks practical 14–16 weeks minimum
Side effect offset after stopping ~2–3 weeks ~6–8 weeks
PCT start (after last injection) ~10–14 days post ~3–4 weeks post
WADA detection window ~12–18 months ~18 months+
Injection frequency Every other day or 3× weekly Weekly or twice weekly

The detection window data is particularly significant and rarely published clearly in competitor content: despite NPP's shorter half-life, its WADA detection window remains approximately 12-18 months — substantially shorter than Deca's 18+ months, but still among the longest of any AAS. Both compounds produce a nandrolone metabolite (19-norandrosterone) detectable in urine by WADA-accredited laboratories for this extended period.

Why Experienced Users Often Prefer NPP Over Deca

Three specific advantages over Deca that competitor content rarely articulates clearly:

  • Side effect management: If prolactin-related issues arise ("NPP dick"), they resolve within 2-3 weeks of stopping rather than 6-8 weeks with Deca — the shorter ester provides a meaningful escape window if the cycle needs to be halted
  • Shorter cycle feasibility: A 10-week NPP cycle actually reaches steady-state and provides effective work time — a 10-week Deca cycle is largely wasted because blood levels barely stabilise before the cycle ends
  • Faster PCT initiation: PCT can begin approximately 10-14 days after the last NPP injection vs 3-4 weeks for Deca — meaningful for recovery timeline

Effects and Benefits

  • Lean mass gains with lower water retention than testosterone at equivalent doses
  • Notable joint comfort benefits during high-volume training — same mechanism as Deca via collagen synthesis effects
  • Faster onset than Deca — reaches effective levels within days rather than weeks
  • More manageable prolactin-related side effects due to faster clearance if needed
  • Lower androgenic activity than testosterone — favourable anabolic-to-androgenic ratio

Side Effects

  • Elevated prolactin from 19-nor activity — Cabergoline is commonly used to manage prolactin-related effects; resolves faster than with Deca when stopping
  • Suppression of natural testosterone — Post Cycle Therapy is required
  • More frequent injection requirement than Deca — every other day or 3× weekly for stable NPP levels
  • Detection window of ~12-18 months despite shorter half-life — relevant for tested athletes
  • Lower aromatisation than testosterone — estrogen management via Arimidex less critical than with testosterone but still possible at higher doses

Dosage and Administration

Experience Level Weekly Dose Injection Frequency Cycle Length
Intermediate 200–300 mg/week Every other day 8–12 weeks
Advanced 300–500 mg/week Every other day or 3× weekly 10–14 weeks

At 150mg/ml, a 1ml injection every other day delivers approximately 300mg/week at 3 injections per week. Every-other-day dosing is preferred over twice-weekly for NPP due to the shorter ~5-day half-life — more frequent injections maintain more stable blood levels and avoid the troughs that would occur with weekly dosing of a 5-day half-life compound.

NPP 150 vs Deca 300 — Which to Choose

  • Choose NPP if: running a shorter cycle (8-12 weeks); want faster side effect resolution if needed; have had prolactin issues with Deca before; prioritise earlier PCT initiation
  • Choose Deca 300 if: running an extended 14-16 week cycle; prefer less frequent injections; comfortable with the longer commitment and slower offset

Building a Cycle Around NPP 150

  • Propionat 100 as a matched short-ester testosterone base — both clear at similar rates for simultaneous PCT
  • Cypionat 250 or Enantat 250 as long-ester bases if running a longer NPP cycle
  • Cabergoline for prolactin management — same requirement as Deca
  • Clomid or Nolvadex for PCT, initiated earlier than with Deca

"NPP 150 is formulated in MCT oil for smooth delivery of this short-ester Nandrolone — the original form of the compound that Deca-Durabolin was designed to replace in 1962, and the form many experienced users now return to for its faster cycle control."

Storage and Handling

Store NPP 150 at room temperature, away from direct sunlight and heat. Use sterile technique for every draw — a fresh needle for drawing and a separate needle for injection is recommended.

Please log in to write review.

Both deliver Nandrolone — the only difference is the ester. NPP uses Phenylpropionate (~5-day half-life) and Deca uses Decanoate (~15-day half-life). This makes NPP reach steady-state in ~25 days versus ~75 days for Deca, allows 8-10 week NPP cycles instead of 14-16 weeks minimum for Deca, and means prolactin-related side effects resolve in 2-3 weeks after stopping NPP versus 6-8 weeks for Deca.

Despite NPP's shorter half-life, its WADA detection window is approximately 12-18 months — shorter than Deca's 18+ months but still among the longest of any AAS. Both produce the same primary metabolite (19-norandrosterone) detectable in urine by WADA-accredited laboratories.

NPP was first — introduced commercially as "Durabolin" by Organon in 1959. Nandrolone Decanoate (Deca-Durabolin) followed in 1962 specifically as a longer-acting version for less frequent injections. NPP is therefore the original Nandrolone compound, with Deca developed to improve convenience.

Every other day or three times weekly minimum for stable blood levels. NPP's ~5-day half-life creates more pronounced peaks and troughs with once-weekly injections — the more frequent schedule maintains the stable levels needed for consistent effects and reduces the trough-associated side effects some users experience.

Three practical reasons: faster side effect resolution if the cycle needs to be stopped (2-3 weeks vs 6-8 weeks); shorter minimum cycle length for meaningful results (8-10 weeks vs 14-16 weeks); earlier PCT initiation (10-14 days post vs 3-4 weeks post for Deca). The trade-off is more frequent injections.

Yes — this is a classic short-ester combination specifically because both Nandrolone Phenylpropionate and Testosterone Propionate have similar half-lives (~5 days and ~2 days respectively), allowing both to clear the system at approximately the same time and enabling PCT to begin simultaneously for both compounds.

Related Products